Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis

By sjmartinez • May 1, 2024

Gu Y, Gebremariam T, Alkhazraji S, Youssef E, El-Gamal S, Matkovits T, Cobb J, Mannino R, Ibrahim AS. Efficacy of an oral lipid nanocrystal formulation of amphotericin B (MAT2203) in the neutropenic mouse model of pulmonary mucormycosis. Antimicrob Agents Chemother. 2024 Apr 30:e0154023. doi: 10.1128/aac.01540-23. Epub ahead of print. PMID: 38687015.

Tags: Amphotericin B, antifungal agents, Harbor UCLA, Infectious Diseases, lipid nanocrystal, liposomal amphotericin B, MAT2203, mucor, mucormycosis, murine, oral amphotericin B, Publications, Rhizopus

A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease

COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators; Bhatt SP, Abadi E, Anzueto A, Bodduluri S, Casaburi R, Castaldi PJ, Cho MH, Comellas AP, Conrad[...]

CAC progression in men and women: Is there an inflection at menopause?

Ishaaya EC, Kinninger A, Schwarzman L, Roy SK, Budoff MJ. CAC progression in men and women: Is there an inflection at menopause? J Cardiovasc Comput[...]

Homebound: Neighborhood Deprivation and Lung Nodule Follow-Up

Benjamin LN, Slatore CG. Homebound: Neighborhood Deprivation and Lung Nodule Follow-Up. Chest. 2025 May;167(5):1268-1270. doi: 10.1016/j.chest.2025.01.035. PMID: 40348508.